Clin Dermatol 1994 Apr-Jun;12(2):201-5
Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Semin Arthritis Rheum 1982 Aug;12(1):52-67
Nihon Rinsho 1975 Jul;33(7):2373-9
G Ital Dermatol Minerva Dermatol 1971 Jan;46(1):40-7
Intern Med J 2006 Aug;36(8):519-23
Department of Immunology, Allergy and Arthritis, Flinders Medical Centre, Adelaide, South Australia, Australia.
Progress in the understanding of the aetiopathogenesis of scleroderma (systemic sclerosis) has been painfully slow and this has greatly impeded the application of specific disease modifying treatments. This article provides a brief historical overview of scleroderma (including the important Australian contribution of Dr Alfred Barnett and colleagues--see accompanying article in this issue on pages 513-18), highlights some recent pathogenic developments and summarises some exciting new therapies. Cautious optimism can now be offered to scleroderma sufferers. Read More